{"url_path":"/sec/nvax/10-k/2026/item-12","section_key":"item-12","section_title":"Item 12 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-02-26","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/0001000694-26-000007-index.html","accession_number":"0001000694-26-000007","cik":"0001000694","ticker":"NVAX","issuer_name":"NOVAVAX INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1000694/0001000694-26-000007-index.html","primary_entity_key":"0001000694","primary_entity_name":"NOVAVAX INC"},"word_count":204,"has_tables":true,"body_markdown":"Item 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS\n\nThe following table provides our equity compensation plan information as of December 31, 2025. Under these plans, our common stock may be issued upon the exercise or vesting of equity awards and purchases under our Employee Stock Purchase Plan (“ESPP”). See also the information regarding our equity awards and ESPP in Note 14 to the consolidated financial statements included herewith.\n\nEquity Compensation Plan Information\n\nPlan CategoryNumber of Securities\nto be Issued\nUpon Exercise of\nOutstanding Options,\nWarrants and Rights\n(a)Weighted-Average\nExercise Price of\nOutstanding\nOptions, Warrants\nand Rights\n(b)Number of Securities\nRemaining Available for\nFuture Issuance Under\nEquity Compensation\nPlans (Excluding\nSecurities Reflected in\nColumn (a))\n(c)\n\nEquity compensation plans approved by security holders(1)\n11,113,586$18.58 7,255,492\n\nEquity compensation plans not approved by security holders (Inducement Plan)(2)\n636,793$10.45 106,290 \n\nTotal\n11,750,379 $17.89 7,361,782 \n\n87\n\n[Table of Contents](#ib45320eea17c45ce95b2b2a9a4dd7402_7)\n\n(1)Includes our 2015 Stock Incentive Plan and ESPP. The weighted-average exercise price in column (b) excludes restricted stock units, which are not subject to an exercise price.\n\n(2)Includes our 2023 Inducement Plan only. The other information required by this item will be included in the 2026 Proxy Statement and is incorporated by reference herein."}